Two Sigma Securities’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Two Sigma Securities’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	-$2.67K	–	3733
2023 Q3	$2.67K	Sell	4 -4	-50%	-$17.1K	﹤0.01%	2817
2023 Q2	$37.4K	Buy	+8	New	+$27.8K	﹤0.01%	2434
2020 Q4	–	Sell	-7	Closed	-$24K	–	2012
2020 Q3	$24K	Buy	+7	New	+$25.1K	﹤0.01%	1231
2020 Q2	–	Sell	-7	Closed	-$14K	–	1829
2020 Q1	$14K	Buy	7 +3	+75%	+$11.2K	﹤0.01%	1241
2019 Q4	$18K	Sell	4 -2	-33%	-$7.67K	﹤0.01%	2268
2019 Q3	$21K	Buy	+6	New	+$36.2K	﹤0.01%	1989
2017 Q3	–	Hold	0	–	-$18K	–	1273
2017 Q2	–	Hold	0	–	–	–	789
2016 Q2	–	Hold	0	–	-$19K	–	542
2016 Q1	–	Hold	0	–	–	–	241

Other funds holding SEEL

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Securities's SEEL Position: Q4 2023 in Review

Two Sigma Securities sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2023, closing a stake of 4 shares — an estimated $2.67K sold.

Two Sigma Securities first reported a position in SEEL in Q3 2019 and held it in 6 quarters. The position peaked at $37.4K in Q2 2023. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.

Two Sigma Securities reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Two Sigma Securities sold 4 Seelos Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $2.67K.
Two Sigma Securities first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
Two Sigma Securities's Seelos Therapeutics, Inc. Common Stock position peaked at $37.4K in Q2 2023.
32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.